Login / Signup
Hyunjin Jung
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Combination Therapy
Smoking Cessation
Human Health
Young Adults
Top Venues
Journal for immunotherapy of cancer
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Young-Seung Kim
,
Seung-Hoon Lee
,
Andrew H Park
,
Chunai Wu
,
Bong-Ki Hong
,
Hyunjin Jung
,
Steven Hsesheng Lin
,
Stephen S Yoo
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1.
Journal for immunotherapy of cancer
12 (3) (2024)
Young-Seung Kim
,
Seung-Hoon Lee
,
Andrew H Park
,
Chunai Wu
,
Bong-Ki Hong
,
Hyunjin Jung
,
Steven Hsesheng Lin
,
Stephen S Yoo
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1.
Journal for immunotherapy of cancer
12 (3) (2024)
Young-Seung Kim
,
Seung-Hoon Lee
,
Andrew H Park
,
Chunai Wu
,
Bong-Ki Hong
,
Hyunjin Jung
,
Steven Hsesheng Lin
,
Stephen S Yoo
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1.
Journal for immunotherapy of cancer
12 (3) (2024)
Young-Seung Kim
,
Seung-Hoon Lee
,
Andrew H Park
,
Chunai Wu
,
Bong-Ki Hong
,
Hyunjin Jung
,
Steven Hsesheng Lin
,
Stephen S Yoo
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1.
Journal for immunotherapy of cancer
12 (3) (2024)
Young-Seung Kim
,
Seung-Hoon Lee
,
Andrew H Park
,
Chunai Wu
,
Bong-Ki Hong
,
Hyunjin Jung
,
Steven Hsesheng Lin
,
Stephen S Yoo
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1.
Journal for immunotherapy of cancer
12 (3) (2024)